Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Hormonal therapies are safe and effective for treating adult women's acne.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Minoxidil effectively treats female pattern hair loss.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.